trials

Meridian Clinical Research Continues to Support Trials at Sites Nationwide, Will Remain Operational Amid COVID-19 Pandemic

Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release.(PRWeb March 24, 2020)Read the full story at https://www.prweb.com/releases/meridian_clinical_research_continues_to_support_trials_at_sites_nationwide_will_remain_operational_amid_covid_19_pandemic/prweb16999427.htm

CenterWatch Announces — Medical Device Trials in the EU: A Guide to the New EU MDR and Revised ISO 14155 Management Report

Conducting device trials in Europe? Report explains EU MDR’s new, complex clinical trial requirements and ISO/DIS 14155:2018 updates.(PRWeb March 24, 2020)Read the full story at https://www.prweb.com/releases/centerwatch_announces_medical_device_trials_in_the_eu_a_guide_to_the_new_eu_mdr_and_revised_iso_14155_management_report/prweb16990930.htm

Clinical Trials Website, ClinicalConnection.com, will List Coronavirus Clinical Trials at No Cost; Public Can Register to Receive Alerts about COVID-19 Clinical Trials

Clinical trials to develop a vaccine to prevent COVID-19 are now underway. Speed is critical in enrolling volunteer participants so that trials can proceed as quickly as possible. ClinicalConnection.com, a leading website for clinical trial searches and notifications will list COVID-19 clinical trials free-of-charge. Members of the public who register to receive free alerts will be notified about COVID-19 trials enrolling in their community that are listed on the website.(PRWeb March 19, 2020)Read the full story at https://www.prweb.com/releases/clinical_trials_website_clinicalconnection_com_will_list_coronavirus_clinical_trials_at_no_cost_public_can_register_to_receive_alerts_about_covid_19_clinical_trials/prweb16989434.htm

Comparator Sourcing in Clinical Trials: Complexities and Bespoke Solutions, Upcoming Webinar Hosted by Xtalks

In this webinar, our speaker will provide a comprehensive overview of the complexities and challenges of sourcing comparators while addressing protocol requirements. She will also provide expert science-based advice on bespoke solutions for successful comparator sourcing.(PRWeb March 18, 2020)Read the full story at https://www.prweb.com/releases/comparator_sourcing_in_clinical_trials_complexities_and_bespoke_solutions_upcoming_webinar_hosted_by_xtalks/prweb16988785.htm

Optimizing the Success of Phase I Hybrid Trials: The Role of a Comprehensive Early Development Plan, Upcoming Webinar Hosted by Xtalks

In this webinar, the speakers will focus on how a comprehensive development plan (CDP) can increase efficiency and success rates in early drug development. They will also explain how Phase I Healthy Volunteer and Patient Hybrid Trials provide signals of potential efficacy and how CDPs are prepared.(PRWeb March 13, 2020)Read the full story at https://www.prweb.com/releases/optimizing_the_success_of_phase_i_hybrid_trials_the_role_of_a_comprehensive_early_development_plan_upcoming_webinar_hosted_by_xtalks/prweb16975442.htm

Segal Trials Screens its First Patient in a study of Psilocybin for Major Depressive Disorder

Over the years, Segal Trials has grown into one of the premier, privately held clinical trial sites in the U.S., with six sites located in South Florida and Charleston, South Carolina focusing on mental health and women’s health; and has been awarded groundbreaking studies such as the use of Psilocybin as a treatment for MDD in the study PSIL201 (ClinicalTrials.gov Identifier: NCT03866174).(PRWeb February 27, 2020)Read the full story at https://www.prweb.com/releases/segal_trials_screens_its_first_patient_in_a_study_of_psilocybin_for_major_depressive_disorder/prweb16937094.htm